Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19).

ABSTRACT:

Background

Since the outbreak of coronavirus disease 2019 (COVID-19), many researchers in China have performed related clinical research. However, systematic reviews of the registered clinical trials are still lacking. Therefore, we conducted a systematic review of clinical trials for COVID-19 to summarize their characteristics.

Methods

This study is based on the PRISMA recommendations in the Cochrane handbook. The Chinese Clinical Registration Center and the ClinicalTrials.gov databases were searched to identify registered clinical trials related to COVID-19. The retrieval inception date was February 9, 2020. Two researchers independently selected the literature based on the inclusion and exclusion criteria, extracted data, and evaluated the risk of bias.

Results

A t

SUBMITTER: Zhu RF 

PROVIDER: S-EPMC7338108 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature